|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Theys J, Yahyanejad S, Habets R, Span P,
Dubois L, Paesmans K, Kattenbeld B, Cleutjens J, Groot AJ,
Schuurbiers OCJ, et al: High NOTCH activity induces radiation
resistance in non small cell lung cancer. Radiother Oncol.
108:440–445. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Baker S, Dahele M, Lagerwaard FJ and Senan
S: A critical review of recent developments in radiotherapy for
non-small cell lung cancer. Radiat Oncol. 11:1152016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Djebali S, Davis CA, Merkel A, Dobin A,
Lassmann T, Mortazavi A, Tanzer A, Lagarde J, Lin W, Schlesinger F,
et al: Landscape of transcription in human cells. Nature.
489:101–108. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hsiao KY, Sun HS and Tsai SJ: Circular
RNA-new member of noncoding RNA with novel functions. Exp Biol Med
(Maywood). 242:1136–1141. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Barbarotto E, Schmittgen TD and Calin GA:
MicroRNAs and cancer: Profile, profile, profile. Int J Cancer.
122:969–977. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mercer TR, Dinger ME and Mattick JS: Long
non-coding RNAs: Insights into functions. Nat Rev Genet.
10:155–159. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wright MW and Bruford EA: Naming ‘junk’:
Human non-protein coding RNA (ncRNA) gene nomenclature. Hum
Genomics. 5:90–98. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ponting CP, Oliver PL and Reik W:
Evolution and functions of long noncoding RNAs. Cell. 136:629–641.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wei S, Du M, Jiang Z, Hausman GJ, Zhang L
and Dodson MV: Long noncoding RNAs in regulating adipogenesis: New
RNAs shed lights on obesity. Cell Mol Life Sci. 73:2079–2087. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lai Y, Chen Y, Lin Y and Ye L:
Down-regulation of LncRNA CCAT1 enhances radiosensitivity via
regulating miR-148b in breast cancer. Cell Biol Int. 42:227–236.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wu D, Li Y, Zhang H and Hu X: Knockdown of
Lncrna PVT1 enhances radiosensitivity in non-small cell lung cancer
by sponging mir-195. Cell Physiol Biochem. 42:2453–2466. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ricciuti B, Mencaroni C, Paglialunga L,
Paciullo F, Crinò L, Chiari R and Metro G: Long noncoding RNAs: New
insights into non-small cell lung cancer biology, diagnosis and
therapy. Med Oncol. 33:182016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sun M, Jin FY, Xia R, Kong R, Li JH, Xu
TP, Liu YW, Zhang EB, Liu XH and De W: Decreased expression of long
noncoding RNA GAS5 indicates a poor prognosis and promotes cell
proliferation in gastric cancer. BMC Cancer. 14:3192014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li W, Huang K, Wen F, Cui G, Guo H and
Zhao S: Genetic variation of lncRNA GAS5 contributes to the
development of lung cancer. Oncotarget. 8:91025–91029.
2017.PubMed/NCBI
|
|
16
|
Cao L, Chen J, Ou B, Liu C, Zou Y and Chen
Q: GAS5 knockdown reduces the chemo-sensitivity of non-small cell
lung cancer (NSCLC) cell to cisplatin (DDP) through regulating
miR-21/PTEN axis. Biomed Pharmacother. 93:570–579. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xue Y, Ni T, Jiang Y and Li Y: Long
noncoding RNA GAS5 inhibits tumorigenesis and enhances
radiosensitivity by suppressing miR-135b expression in non-small
cell lung cancer. Oncol Res. 25:1305–1316. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cron KR, Zhu K, Kushwaha DS, Hsieh G,
Merzon D, Rameseder J, Chen CC, D'Andrea AD and Kozono D:
Proteasome inhibitors block DNA repair and radiosensitize non-small
cell lung cancer. PLoS One. 8:e737102013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kim W, Youn H, Seong KM, Yang HJ, Yun YJ,
Kwon T, Kim YH, Lee JY, Jin YW and Youn B: PIM1-activated PRAS40
regulates radioresistance in non-small cell lung cancer cells
through interplay with FOXO3a, 14-3-3 and protein phosphatases.
Radiat Res. 176:539–552. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu L, Wang HJ, Meng T, Lei C, Yang XH,
Wang QS, Jin B and Zhu JF: lncRNA GAS5 inhibits cell migration and
invasion and promotes autophagy by targeting miR-222-3p via the
GAS5/PTEN-signaling pathway in CRC. Mol Ther Nucleic Acids.
17:644–656. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Huang J, Xie N, Huang H, Yao J and Hu W:
Long noncoding RNA STXBP5-AS1 inhibits cell proliferation,
migration, and invasion via preventing the PI3K/AKT against STXBP5
expression in non-small-cell lung carcinoma. J Cell Biochem.
18:280232018.
|
|
22
|
Zhang YL, Li XB, Hou YX, Fang NZ, You JC
and Zhou QH: The lncRNA XIST exhibits oncogenic properties via
regulation of miR-449a and Bcl-2 in human non-small cell lung
cancer. Acta Pharmacol Sin. 38:371–381. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wei Y, Yan Z, Wu C, Zhang Q, Zhu Y, Li K
and Xu Y: Integrated analysis of dosage effect lncRNAs in lung
adenocarcinoma based on comprehensive network. Oncotarget.
8:71430–71446. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Dong Z, Li S, Wang X, Si L, Ma R, Bao L
and Bo A: lncRNA GAS5 restrains CCl4-induced hepatic fibrosis by
targeting miR-23a through the PTEN/PI3K/Akt signaling pathway. Am J
Physiol Gastrointest Liver Physiol. 316:G539–G550. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li Y, Gu J and Lu H: The GAS5/miR-222 axis
regulates proliferation of gastric cancer cells through the
PTEN/Akt/mTOR pathway. Dig Dis Sci. 62:3426–3437. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wickramasinghe NS, Manavalan TT, Dougherty
SM, Riggs KA, Li Y and Klinge CM: Estradiol downregulates miR-21
expression and increases miR-21 target gene expression in MCF-7
breast cancer cells. Nucleic Acids Res. 37:2584–2595. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu HY, Zhang YY, Zhu BL, Feng FZ, Yan H,
Zhang HY and Zhou B: MiR-21 regulates the proliferation and
apoptosis of ovarian cancer cells through PTEN/PI3K/AKT. Eur Rev
Med Pharm Sci. 23:4149–4155. 2019.
|
|
29
|
Liu H, Wang J, Tao Y, Li X, Qin J, Bai Z,
Chi B, Yan W and Chen X: Curcumol inhibits colorectal cancer
proliferation by targeting miR-21 and modulated PTEN/PI3K/Akt
pathways. Life Sci. 221:354–361. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhu Y, Tang H, Zhang L, Gong L, Wu G, Ni J
and Tang X: Suppression of miR-21-3p enhances TRAIL-mediated
apoptosis in liver cancer stem cells by suppressing the
PI3K/Akt/Bad cascade via regulating PTEN. Cancer Manag Res.
11:955–968. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Schneider C, King RM and Philipson L:
Genes specifically expressed at growth arrest of mammalian cells.
Cell. 54:787–793. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kino T, Hurt DE, Ichijo T, Nader N and
Chrousos GP: Noncoding RNA gas5 is a growth arrest- and
starvation-associated repressor of the glucocorticoid receptor. Sci
Signal. 3:ra82010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mei Y, Si J, Wang Y, Huang Z, Zhu H, Feng
S, Wu X and Wu L: Long noncoding RNA GAS5 suppresses tumorigenesis
by inhibiting miR-23a expression in non-small cell lung cancer.
Oncol Res. 25:1027–1037. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bian D, Shi W, Shao Y, Li P and Song G:
Long non-coding RNA GAS5 inhibits tumorigenesis via miR-137 in
melanoma. Am J Transl Res. 9:1509–1520. 2017.PubMed/NCBI
|
|
35
|
Guo LJ, Zhang S, Gao B, Jiang Y, Zhang XH,
Tian WG, Hao S, Zhao JJ, Zhang G, Hu CY, et al: Low expression of
long non-coding RNA GAS5 is associated with poor prognosis of
patients with thyroid cancer. Exp Mol Pathol. 102:500–504. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yan H, Zhang DY, Li X, Yuan XQ, Yang YL,
Zhu KW, Zeng H, Li XL, Cao S, Zhou HH, et al: Long non-coding RNA
GAS5 polymorphism predicts a poor prognosis of acute myeloid
leukemia in Chinese patients via affecting hematopoietic
reconstitution. Leuk Lymphoma. 58:1948–1957. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wen Q, Liu Y, Lyu H, Xu X, Wu Q, Liu N,
Yin Q, Li J and Sheng X: Long noncoding RNA GAS5, which acts as a
tumor suppressor via microRNA 21, regulates cisplatin resistance
expression in cervical cancer. Int J Gynecol Cancer. 27:1096–1108.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ma N, Li S, Zhang Q, Wang H, Qin H and
Wang S: Long non-coding RNA GAS5 inhibits ovarian cancer cell
proliferation via the control of microRNA-21 and SPRY2 expression.
Exp Ther Med. 16:73–82. 2018.PubMed/NCBI
|
|
39
|
Poliseno L and Pandolfi PP: PTEN ceRNA
networks in human cancer. Methods. 77-78:41–50. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
He Y, Mingyan E, Wang C, Liu G, Shi M and
Liu S: CircVRK1 regulates tumor progression and radioresistance in
esophageal squamous cell carcinoma by regulating
miR-624-3p/PTEN/PI3K/AKT signaling pathway. Int J Biol Macromol.
125:116–123. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wei H, Cui R, Bahr J, Zanesi N, Luo Z,
Meng W, Liang G and Croce CM: Mir-130a deregulates PTEN and
stimulates tumor growth. Cancer Res. 77:6168–6178. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wu Y, Song Y, Xiong Y, Wang X, Xu K, Han
B, Bai Y, Li L, Zhang Y and Zhou L: MicroRNA-21 (Mir-21) promotes
cell growth and invasion by repressing tumor suppressor PTEN in
colorectal cancer. Cell Physiol Biochem. 43:945–958. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
He C, Dong X, Zhai B, Jiang X, Dong D, Li
B, Jiang H, Xu S and Sun X: MiR-21 mediates sorafenib resistance of
hepatocellular carcinoma cells by inhibiting autophagy via the
PTEN/Akt pathway. Oncotarget. 6:28867–28881. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Liu H, Li H, Jin L, Li G, Hu S, Ning C,
Guo J, Shuai S, Li X and Li M: Long noncoding RNA GAS5 suppresses
3T3-L1 cells adipogenesis through miR-21a-5p/PTEN signal pathway.
DNA Cell Biol. 37:767–777. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Haddadi N, Lin Y, Travis G, Simpson AM,
Nassif NT and McGowan EM: PTEN/PTENP1: ‘Regulating the regulator of
RTK-dependent PI3K/Akt signalling’, new targets for cancer therapy.
Mol Cancer. 17:372018. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Wang J, Xu J, Fu J, Yuan D, Guo F, Zhou C
and Shao C: MiR-29a regulates radiosensitivity in human intestinal
cells by targeting PTEN gene. Radiat Res. 186:292–301. 2016.
View Article : Google Scholar : PubMed/NCBI
|
